Literature DB >> 32288468

New method of preparation of carboxy-protected amino acid conjugates of glycyrrhizinic acid.

L A Baltina1, A I Fairushina1, L A Baltina1.   

Abstract

A method for preparation of carboxy-protected amino acid conjugates of glycyrrhizinic acid with the use of N-hydroxybenzotriazole, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, and methyl esters of L-amino acids (phenylalanine, tyrosine, leucine, isoleucine, and methionine) in 85-90% yield was developed. The structure of the prepared compounds was confirmed by IR and 13C NMR spectra. © Pleiades Publishing, Ltd. 2016.

Entities:  

Keywords:  1-(3-dimethylaminopropyl)-3-ethylcarbodiimide; N-hydroxybenzotriazole; amino acids methyl esters; glycopeptides; glycyrrhizinic acid

Year:  2016        PMID： 32288468      PMCID： PMC7104129          DOI： 10.1134/S1070363216040113

Source DB:  PubMed          Journal:  Russ J Gen Chem        ISSN： 1070-3632            Impact factor:   0.868


  9 in total

Review 1.  Natural products to drugs: natural product derived compounds in clinical trials.

Authors:  Mark S Butler
Journal:  Nat Prod Rep       Date:  2005-03-08       Impact factor: 13.423

Review 2.  Antivirals of ethnomedicinal origin: structure-activity relationship and scope.

Authors:  Debprasad Chattopadhyay; Trailokya N Naik
Journal:  Mini Rev Med Chem       Date:  2007-03       Impact factor: 3.862

3.  Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.

Authors:  Gerold Hoever; Lidia Baltina; Martin Michaelis; Rimma Kondratenko; Lia Baltina; Genrich A Tolstikov; Hans W Doerr; Jindrich Cinatl
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

Review 4.  Antiviral properties of glycyrrhizic acid and its semisynthetic derivatives.

Authors:  Raffaello Pompei; Samuela Laconi; Angela Ingianni
Journal:  Mini Rev Med Chem       Date:  2009-07       Impact factor: 3.862

Review 5.  Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine.

Authors:  L A Baltina
Journal:  Curr Med Chem       Date:  2003-01       Impact factor: 4.530

6.  [Synthesis and immunomodulating activity of new diglycopeptides of of glycyrrhizinic acid and it's 30-methyl ester].

Authors:  R M Kondratenko; L A Baltina; E V Vasil'eva; Kh M Nasyrov; R M Kireeva; N Zh Baschenko; S M Fridman; L A Baltina; G A Tolstikov
Journal:  Bioorg Khim       Date:  2004 Mar-Apr

7.  Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.

Authors:  Jung-Chung Lin; Jaw-Ming Cherng; Man-Shan Hung; Lidia A Baltina; Lia Baltina; Rimma Kondratenko
Journal:  Antiviral Res       Date:  2008-03-31       Impact factor: 5.970

8.  [Synthesis and biological activity of new glycyrrhizic acid conjugates with amino acids and dipeptides].

Authors:  L A Baltina; R M Kondratenko; L A Baltina; N Zh Baschenko; O A Pliasunova
Journal:  Bioorg Khim       Date:  2009 Jul-Aug

9.  Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review).

Authors:  L A Baltina; R M Kondratenko; L A Baltina; O A Plyasunova; A G Pokrovskii; G A Tolstikov
Journal:  Pharm Chem J       Date:  2010-02-04       Impact factor: 0.837
  9 in total
  2 in total

1.  Glycyrrhizic acid derivatives as Dengue virus inhibitors.

Authors:  Lidia A Baltina; Yan-Ting Tasi; Su-Hua Huang; Hsueh-Chou Lai; Lia A Baltina; Svetlana F Petrova; Marat S Yunusov; Cheng-Wen Lin
Journal:  Bioorg Med Chem Lett       Date:  2019-08-29       Impact factor: 2.823

2.  Synthesis of Glycyrrhizic Acid Conjugates with S-Benzyl-L-Cysteine and Their Antiviral Activity.

Authors:  L A Baltina; R M Kondratenko; L A Baltina; O A Plyasunova
Journal:  Pharm Chem J       Date:  2021-06-14       Impact factor: 0.837
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.